Literature DB >> 15818037

Thoracoscopic decortication: first-line therapy for pediatric empyema.

Y-T Chang1, Z-K Dai, E-L Kao, S-H Chou, Meei-Feng Huang.   

Abstract

Video-assisted thoracoscopic surgery (VATS) has become a popular and well-refined procedure. It has several advantages over open thoracotomy in terms of invasiveness and cosmetics. The aim of this study is to consider if VATS can serve as primary management for pediatric empyema. Between October 2000 and December 2002, 13 children with empyema receiving VATS were retrospectively reviewed. Of them, 5 had tube thoracostomy before VATS intervention (group T), and 8 had VATS as the initial treatment (group V). Their mean (+/- SD) age of groups V and T were 5.75 +/- 4.43 and 4.0 +/- 1.58 years, respectively. The children of group V had a shorter length of hospital stay (group V 10.7 +/- 3.54 days; group T 28.2 +/- 8.32 days), a shorter period of chest tube drainage (group V 5 +/- 1.87 days; group T 25 +/- 11.08 days), less transfusion (group V 0.4 +/- 0.17 units; group T 0.9 +/- 0.27 units) and less radiation exposure (group V 10.3 +/- 3.49; group T 23.4 +/- 11.64). No mortality was noted in the entire series. We conclude that primary VATS is a safe, effective and definitive method which can serve as first-line therapy for children with empyema.

Entities:  

Mesh:

Year:  2005        PMID: 15818037     DOI: 10.1159/000083143

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  3 in total

1.  Less is best? The impact of urokinase as the first line management of empyema thoracis.

Authors:  B A Khalil; P A Corbett; M O Jones; C T Baillie; Kevin Southern; P D Losty; S E Kenny
Journal:  Pediatr Surg Int       Date:  2006-09-30       Impact factor: 1.827

2.  The role of thoracoscopy in the treatment of pleural empyema in children.

Authors:  J Dzielicki; W Korlacki
Journal:  Surg Endosc       Date:  2006-07-03       Impact factor: 4.584

Review 3.  Management of community-acquired pneumonia in children.

Authors:  Krishne Chetty; Anne H Thomson
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.